The U.S. Food and Drug Administration has approved a new surgical tool for use in certain gynecological procedures, the device’s maker, Olympus America Inc., announced Wednesday. The PK Morcellator is an electrical device intended for cutting and removing tissue in laparoscopic... 
By Michelle Llamas 
Taking acid-reducing drugs called proton pump inhibitors and an antibiotic together may increase the risk for life-threatening irregular heartbeat, according to a study. Researchers from Columbia University Medical Center and the Data Science Institute at Columbia University...
By Michelle Llamas 
Families who filed lawsuits against GlaxoSmithKline say a new label for Zofran (ondansetron) shows the drugmaker could have warned about birth-defect risks sooner. The new label links the anti-nausea drug to cardiovascular and cleft-palate birth defects for the first time. The...
By Michelle Llamas 
The U.S. Food and Drug Administration released its final guidelines on the controversial Essure Permanent Birth Control System, and women injured by the device say the agency failed them. “The guidance includes a ‘suggested’ black-box warning along with a patient decision...
By Michelle Llamas 
People who use proton pump inhibitors (PPIs) to control stomach acid are more likely to end up in the hospital with infectious gastroenteritis, also known as stomach flu, researchers found. Doctors prescribe PPIs like Nexium (esomeprazole) and Prilosec (omeprazole) to treat...
By Michelle Llamas 
Johnson & Johnson received its third trial loss in a row over claims its talc powder can cause ovarian cancer after a St. Louis jury recently awarded nearly $70 million to a cancer patient. In a 9-3 vote, the jury awarded compensatory and punitive damages to 63-year-old...
By Michelle Llamas 
A study found people who lost weight with the Type 2 diabetes drug Invokana (canagliflozin) got hungrier and ate more, leading to a weight loss plateau. The study conducted by David Polidori and colleagues will publish in Obesity during Obesity Week 2016, which runs from Oct. 13...
By Michelle Llamas 
The U.S. Food and Drug Administration created a program that allows medical device makers to hide adverse events and report them years later, the Star Tribune reported. Doctors and patients should be able to use this data to make informed decisions about treatment options, but...
By Michelle Llamas 
After critics accused Johnson & Johnson and Bayer of hiding data in clinical trials for their blockbuster blood thinner Xarelto (rivaroxaban), the U.S. Food and Drug Administration said the drug is safe and effective. Since its approval in 2011, Xarelto has made billions for... Page 4 of 17
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.